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Background. Knowledge, attitudes, and practices of obstetricians and gynecologists regarding the Centers for Disease Control and
Prevention (CDC) recommendations for prevention of healthcare-associated group A streptococcal (GAS) infections as well as
general management of pregnancy-related and postpartum infections are unknown. Methods. Questionnaires were sent to 1300
members of the American College of Obstetricians and Gynecologists. Results. Overall, 53% of providers responded. Postpartum
and postsurgical infections occurred in 3% and 7% of patients, respectively. Only 14% of clinicians routinely obtain diagnostic
specimens for postpartum infections; providers collecting specimens determined the microbial etiology in 28%. Microbiologic di-
agnoses were conﬁrmed in 20% of postsurgical cases. Approximately 13% and 15% of postpartum and postsurgical infections for
which diagnoses were conﬁrmed were attributed to GAS, respectively. Over 70% of clinicians were unaware of CDC recommenda-
tions.Conclusions.Postpartumand postsurgicalinfections are common.Providing empirictreatment without attainingdiagnostic
cultures represents a missed opportunity for potential prevention of diseases such as severe GAS infections.
Copyright © 2007 Chris A. Van Beneden et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Pregnant women are at risk of infection during labor and
delivery; most infections of the female pelvic organs oc-
cur when normal ﬂora of the female genital or gastroin-
testinal tract contaminate the normally sterile amniotic ﬂuid
and uterus. These bacteria can become pathogenic, partic-
ularly in devitalized tissue [1]. Bacterial infections in preg-
nant women may also originate from inoculation of bac-
teria during childbirth or surgery or from hematogenous
spread [2]. Uterine infections are much more common af-
ter Cesarean delivery (C-section) than following a vaginal
delivery [3]. Fortunately, postpartum or puerperal infec-
tions have decreased over the last hundred years due to im-
proved procedures and eﬀective antibiotic use. However, in-
fections still cause about 13% of pregnancy-related deaths
and are the ﬁfth leading cause of death among this popu-
lation [1].
Group A Streptococcus (GAS), or Streptococcus pyogenes,
is an uncommon, but serious and potentially preventable
cause of postpartum and postsurgical infections. The inci-
dence of conﬁrmed GAS infections among deliveries in a
studyinJerusalemover6.5yearsrangedfrom0.33to3.16per
1000 births; suspected intra- or postpartum GAS infections
occurred in 13.2% of all deliveries [4] .I nar e v i e wo fr e c o r d s
of all mothers and babies with GAS bacteremia in the United
Kingdom from 1980–1999, peripartum GAS infection oc-
curred in 1 of every 11,000 live births [5]. The source of a
sporadic postpartum GAS infection is typically unknown,
but outbreaks of postpartum and postsurgical GAS infec-
tions have been associated with colonized healthcare work-
ers. Healthcare workers who were asymptomatic carriers of
GAS have been identiﬁed in 15 of 21 outbreaks of postpar-
tum and postsurgical infections reported from 1976 through
2005 [6–26]; these infections represent a preventable mani-
festation of severe GAS disease.2 Infectious Diseases in Obstetrics and Gynecology
In 2002, the Centers for Disease Control and Prevention
(CDC) published guidelines for prevention of secondary in-
vasive GAS infections, including those among postpartum
and postsurgical patients [27]. Recommended strategies for
theinvestigationofbothasinglecaseandclustersofpostpar-
tumorpostsurgicalGASinfectionweredeveloped.Inbrief,a
singlehealthcare-associatedinfectionshouldtriggernotiﬁca-
tion of the hospital infection control practitioner, enhanced
surveillance for additional cases and storage of GAS patient
isolates for potential strain characterization. When two or
more postpartum or postsurgical cases occur in the same
healthcare facility within six months, CDC recommends that
epidemiologic links between the cases be investigated, in-
cludingscreeningforGAScolonizationofhealthcareperson-
nel linked to known cases.
Although these guidelines were published in 2002, the
level of awareness and adherence to these recommendations
is unknown. Also, clinician knowledge and management of
pregnancy-related and postsurgical infections has not been
assessed. We conducted a survey of obstetric and gyneco-
logic providers (OB/GYNs) to estimate the frequency of in-
trapartum, postpartum, and postsurgical infections they en-
counter to determine bacterial culturing practices among
providers, and to estimate the frequency of GAS isolation
among the respondents’ patient populations. We also sought
to estimate awareness and adherence to the CDC guide-
lines, assess barriers to following the guidelines, and query
providers regarding more eﬀective methods for distributing
these recommendations.
2. SUBJECTS AND METHODS
In July 2005, an anonymous questionnaire focusing on cur-
rent practices regarding intrapartum, postpartum, and post-
surgical infections was mailed to 1300 American College of
Obstetricians and Gynecologists (ACOG) Fellows and Junior
Fellows in Practice; 1000 subjects were members of the Col-
laborative Ambulatory Research Network (CARN). Mem-
bers of CARN are practicing OB/GYNs who have volun-
teered to participate regularly in surveys, facilitating assess-
ment of clinical practice patterns, and aiding development of
educational materials. The remaining 300 subjects consisted
of a computer-generated random sample of ACOG Fellows
and Junior Fellows in practice who are practicing obstet-
rics and/or gynecology and had not received a survey from
ACOG during the previous two years (non-CARN). A sec-
ond mailing was sent approximately ﬁve weeks after the ﬁrst
to those individuals who did not initially respond. A ﬁnal re-
minder mailing was sent approximately six weeks later. All
survey respondents who reported performing deliveries or
surgeries in 2004 were eligible for inclusion in our analysis.
The survey included questions about the practitioner’s
age and training, his/her practice, patient population demo-
graphics, and speciﬁc questions assessing experience with di-
agnosingandtreatingintrapartum,postpartum(e.g.,wound
infections,endometritis,bacteremia),andpostsurgicalinfec-
tions (e.g., wound infections, endometritis, vaginal cuﬀ cel-
lulitis, bacteremia), particularly infections potentially due to
GAS. Survey respondents were asked to estimate the racial
and ethnic distributions of their patient population, number
of deliveries and surgeries performed and related infections
seen during 2004. Questions also assessed the practitioner’s
use and understanding of the CDC guidelines for prevention
of GAS infections among postpartum and postsurgical pa-
tients. Question formats were primarily multiple choice or
opinion questions using a scaled response.
Survey responses were double-entered into an American
StandardCodeforInformationInterchange(ASCII)ﬁle,cor-
rected for data entry errors, and converted into an SAS 9
database (SAS Institute, Cary, NC, USA). The racial and eth-
nic characteristics of the provider’s patient population were
dichotomized into the following categories, based on the dis-
tribution of responses: less than 80% white versus 80% or
more white; less than 25% versus 25% or more black; less
than 20% versus 20% or more Hispanic; less than 7% ver-
sus 7% or more Asian/Paciﬁc Islander. The percentage of pa-
tients with Medicaid was divided into low (<25%), medium
(25–49%), and high (≥50%) categories. Diﬀerences in cat-
egorical measures were assessed using the chi-square test.
The Wilcoxon 2-sample test was used to compare medi-
ans among continuous measures. All analyses were tested
for signiﬁcance using a P value of <.05. Comparisons of
responses by CARN and non-CARN members were com-
pleted for all survey questions. All statistically signiﬁcant dif-
ferences between CARN and non-CARN are presented; oth-
erwise the results for both CARN and non-CARN combined
are shown.
3. RESULTS
3.1. Demographicsandpracticecharacteristicsof
surveyrespondents
Completed surveys were returned by 614 (61%) CARN and
75(24%)non-CARNmembers(53%ofallrespondents).Re-
spondents who had not performed deliveries or surgeries in
2004 (54 CARN and 6 non-CARN respondents) were ex-
cluded. Demographic and practice characteristics of the re-
maining 629 survey respondents are detailed in Table 1.A
majority of respondents practiced in a group setting, worked
inanurbanorsuburbanlocation,andconsideredthemselves
specialists. Members of CARN were older and more likely
than nonmembers to be male and to have been in practice
for 10 or more years. Signiﬁcant diﬀerences in sex of the re-
spondents and number of years in practice among CARN
versus non-CARN members did not persist when control-
ling for age: age and years of experience were highly cor-
related (Pearson Correlation Coeﬃcient, R = 0.91; P<
.0001).
3.2. Obstetricandgynecologicprocedures
performedin2004
Nearly all providers performed both deliveries (vaginal or
Cesarean) (91%) and surgeries (hysterectomies or Cesarean
deliveries) (96%) in the year preceding the survey. Based on
respondents estimates, the median number (and range) of
vaginal deliveries performed per provider in 2004 were 120Chris A. Van Beneden et al. 3
Table 1: Demographics and practice characteristics of survey respondents in the Collaborative Ambulatory Research Network (CARN) and
non-CARN groups.
Characteristic CARN (n = 560) Non-CARN (n = 69)
Median age (in years) 48 (30–85) 40 (29–67)∗
Male sex (%) 56 44†
Years (y) in practice:
median (range) 16 (1–55) 6 (0–34)∗
<10 y 31 57
10–19 y 32 19
≥20 y 37 25
Practice type:
Solo or two-person practice (%) 27 25
University (%) 10 17
Multi-specialty group (%) 10 10
OB/GYN group (%) 44 39
Primary specialty:
OB/GYN (%) 83 83
GYN only (%) 9 6
Maternal/fetal medicine (%) 5 7
Professional identity:
Specialist (%) 63 67
Primary care & specialist (%) 35 30
Practice location:
Urban (%) 44 42
T o w n ,m i d - s i z e d( % ) 2 0 2 3
Suburb (%) 27 26
Rural (%) 7 6
Patients receiving Medicaid (%)
<25% 58 59
25–49% 20 17
≥50% 22 23
Race/ethnicity of patients:
≥25% Black (%) 26 23
≥20% Hispanic (%) 27 28
≥7% Asian/Paciﬁc Islander 19 26
∗Wilcoxon 2-sample test, P<. 001.
†Chi-square, P = .003.
(4–512) (n = 568 survey respondents), and a median of
55 (range: 1–450) surgeries were performed per provider in
2004 (n = 596 respondents).
3.3. Experiencewithintrapartum,postpartum,and
postsurgicalinfections
Intrapartuminfections
Based on respondents’ estimates, the median number of pa-
tients (per provider) who developed intraamniotic infection
or chorioamnionitis in the year preceding the survey was ﬁve
(range: 0–100). Nearly all respondents (91% of 568) stated
that they would treat an intraamniotic infection empirically,
without obtaining a complete blood count or blood culture
or waiting for the results of either test if obtained. Over half
of respondents believe thatthe most common bacterialcause
of intraamniotic infections is polymicrobial (Table 2). With
increasing years of experience, providers were more likely
to consider gram-negative rods the most common bacterial
cause of intraamniotic infections and less likely to consider
the cause polymicrobial in origin (chi-square test for linear
trend: P <.001 for each).
Postpartumandpostsurgicalinfections
Persurveyrespondents,anestimated3%ofpatientswhohad
vaginal deliveries developed a postpartum infection, and 7%4 Infectious Diseases in Obstetrics and Gynecology
of patients undergoing surgery (Cesarean delivery or hys-
terectomy) developed postsurgical infections. Over half of
providersstatedthattheydonotobtaindiagnosticspecimens
from their patients with postpartum infections; only 14% al-
ways obtain specimens. Providers with increasing years of
experience were more likely to routinely obtain specimens
for microbiological diagnosis of postpartum infections (chi-
square test for linear trend: P = .002). Those who consid-
ered themselves both primary care physicians and specialists
were more likely to routinely obtain cultures than respon-
dents who considered themselves specialists only (21% ver-
sus 10%; P<. 001). This association persisted when control-
ling for years of experience (P = .002). The suspected fre-
quency of Staphylococcus aureus and group B streptococcal
infections diﬀe r e df o rp o s t p a r t u mc o m p a r e dt op o s t s u r g i c a l
infections (Table 2).
In general, more providers either always (18%) or some-
times (52%) obtained cultures from patients with postsur-
gical infections compared to those with postpartum infec-
tions; only 30% empirically treated without obtaining spec-
imens. Providers with increasing years of experience were
more likely to always obtain specimens from patients with
postsurgical infections (chi-square test for linear trend: P =
.004).Aswithpostpartuminfections,thoserespondentswho
considered themselves both primary care providers and spe-
cialists were more likely to routinely obtain specimens than
those who considered themselves specialists (P = .001).
When asked to estimate how many of their patients de-
veloped a postpartum infection or a postsurgical infection
that was caused by GAS in the previous year, 384 and 472
providers responded, respectively. The numbers of estimated
GAS-speciﬁc infections for all providers combined were 81
postpartum and 81 postsurgical GAS infections.
3.4. GASscreening
When GAS is isolated during routine rectovaginal culture
for group B Streptococcus (GBS), 9% of respondents stated
that they would treat the patient with antibiotics, 15% would
give intrapartum antibiotic prophylaxis similar to manage-
ment of GBS, most respondents (64%) would do nothing,
and 8% stated that they either do not see this organism or
their laboratory does not routinely test rectovaginal cultures
for GAS.
3.5. KnowledgeofGASpostpartumand
postsurgicalinfectionepidemiology
The majority of survey respondents correctly indicated that
each of the ﬁve body sites listed (oropharynx, nares, rec-
tum,vagina,andskin)maybecolonizedbyGAS(Table 3)al-
though less than half (47%) chose all ﬁve sites. Respondents
chose the following as possible causes of a cluster of post-
partum or postsurgical GAS infection in a facility: healthcare
worker is a GAS carrier (44% respondents); patient is colo-
nized prior to delivery or surgery (28%); or, poor infection
control practices (23%). Answers given to questions about
potential sites of GAS colonization and possible causes of
clusters did not vary by provider characteristics such as years
in practice or practice type.
3.6. Adherenceandbarrierstofollowing
CDC’sGASguidelines
When questioned about action taken when a postpartum or
postsurgical GAS infection is identiﬁed, 25% would contact
infectioncontrolpersonnel.Fewrespondentschosetheother
two actions recommended in the CDC guidelines (save GAS
isolatesforfurtherstudy;enhancesurveillanceforsuchinfec-
tions) (Table 3). The majority (73%) of respondents stated
thattheyhadnotdiagnosedanyGASinfections.Thepropor-
tion of respondents who would take actions recommended
in the guidelines increased with increasing years in practice;
the proportion was also higher among providers with prac-
tices in rural areas. Few survey respondents correctly iden-
tiﬁed the number of postpartum or postsurgical GAS infec-
tions that should trigger infection control notiﬁcation and
investigation if the infections occurred in the same facility
within six months: 23% stated correctly that two such infec-
tions should elicit this response (Table 3). CARN members
(26%) more frequently chose this response than non-CARN
members (4%; P<. 01). No signiﬁcant associations between
choosing the correct response and other provider character-
istics (i.e., years in practice, practice type or location) were
noted.
Only 5.6% of respondents (n = 611) stated that they
were familiar with the 2002 CDC guidelines for management
of GAS infections; in fact, over 70% were unaware of their
existence. Other barriers to learning about or following the
guidelines included: perceived infrequency of GAS infections
in the respondent’s practice (18%), publication in a journal
not routinely read (13%), the fact that the provider does not
consider GAS infection a priority disease (9%), and a lack
of culture results for postpartum and postsurgical infections
(4%). Most (74%) respondents stated that they do follow
guidelines regarding diagnostic, management, or treatment
of postpartum and postsurgical infections, principally those
by ACOG (59%) and those which are part of hospital infec-
tion control protocols (32%).
4. DISCUSSION
Our study is the ﬁrst published survey of the knowledge, at-
titudes, and practices of OB/GYNs regarding the perceived
frequency, etiology, and management of intrapartum, post-
partum, and postsurgical infections. Among a large number
of OB/GYNs, we found that most empirically treat a vari-
ety of infections encountered in their routine practice. Al-
though this approach is within current standards of care, this
presents a missed opportunity for the identiﬁcation and po-
tential prevention of illnesses such as severe GAS infections.
Bothoursurveyandthecurrentliteraturesuggestthatin-
traamniotic, postpartum, and postsurgical infections are not
uncommon. The providers in our survey identify approxi-
mately three postpartum infections per 100 vaginal deliver-
ies and 7 postsurgical infections per 100 Cesarean deliver-
ies and hysterectomies. These estimates are conservative, asChris A. Van Beneden et al. 5
Table 2: Respondents’ perception of most common bacterial etiology of intrapartum, postpartum, and postsurgical infections‡.
Most common bacterial etiology % Type of infection
Intrapartum (n = 572) Postpartum (n = 534) Postsurgical (n = 556)
Staphylococcus aureus 0.2 3 23
Group B Streptococcus 19 13 1
Polymicrobial 57 62 52
Gram-negative rod 22 20 19
Anaerobes 3 −† −†
Group A Streptococcus −† 0.8 2
∗Values are %.
†Not applicable (not included in multiple choice).
‡Respondents were only allowed one choice for each type of infection.
Table 3: Survey respondents’ knowledge and expected practice patterns regarding group A streptococcal (GAS) postpartum (PP) and post-
surgical (PS) infections.
Knowledge or expected practice CARN, % Non-CARN, %
Which body sites can GAS colonize?∗ (n = 569) (n = 530) (n = 66)
Oropharynx (%) 87 80
Nares (%) 88 83
Rectum (%) 75 74
Vagina (%) 78 77
Skin (%) 75 62†
All the above (%) 48 38
What is most likely cause of GAS PP or PS cluster in the same (n = 521) (n = 65)
facility in a 6-month period of time? (n = 586)
Poor infection control practices: 24 19
Healthcare worker is a GAS carrier: 44 42
Patient was colonized prior to delivery or surgery: 27 34
Chance: 56
What action do you take when you recognize a PP or PS GAS (n = 535) (n = 65)
infection among your hospitalized patients?∗ (n = 600)
Contact infection control: 26 15
Save isolates from patients: 9 6
Enhanced surveillance: 10 8
Give antibiotic prophylaxis to other hospitalized patients: 2 2
Take no speciﬁc action: 7 15§
I have not seen any GAS infections: 74 71
What number of PP or PS GAS infections should trigger (n = 218) (n = 29)
infection control notiﬁcation and investigation if occurring in
same facility within 6 months? (n = 247)
0: 0.9 4
1: 22 17
2: 26 4±
3–5: 35 41
6o rm o r e : 16 35
∗Respondent could choose more than one answer.
†Chi-square P value = .03.
§Chi-square P value = .01.
±Chi-square P value < .01.6 Infectious Diseases in Obstetrics and Gynecology
they do not include deliveries by other providers (e.g., family
practitioners), but are consistent with previous estimates in
the literature. Intraamniotic infections have been reported to
range from 0.5% to 10.5% of all pregnancies, occurring in 1–
5% of term pregnancies and up to 10% in patients with pre-
maturelabor[28–32].Puerperalorpostpartumendometritis
has been reported to occur in 1–3% of women with vaginal
deliveries and among 5–15% of women having scheduled re-
peat Cesarean deliveries [1, 28].
Nearly all survey respondents treat intrapartum, post-
partum, and postsurgical infections empirically although
providers are more likely to obtain diagnostic specimens
from patients with postsurgical infections. While no formal-
ized guidelines on diagnostic management of intrapartum
and postpartum infections exist, empiric therapy is not con-
trary to current practice recommendations. Recently devel-
oped ACOG guidelines on the use of prophylactic antibiotics
in labor and delivery recommend the use of prophylactic an-
tibiotics in both high- and low-risk patients undergoing Ce-
sarean delivery although the data to support use among low-
risk patients is inconclusive [33]. Blood cultures are typi-
cally taken only when the patient does not respond to em-
piric antibiotics or if complications arise [34]. The rationale
for not obtaining diagnostic cultures is multifold; antibiotic
therapy is typically empiric and based on clinical diagnosis,
patientsoftenrespondtoantibioticsbeforecultureresultsare
known, anaerobes are notoriously diﬃcult to isolate, accu-
rate postpartum endometrial specimens are diﬃcult to ob-
tain because of possible contamination by the lower genital
tract, and cultures add cost and time [35].
Conversely, pretreatment cultures facilitate management
of patients who fail initial empiric antibiotic [36]. Tai-
loring antimicrobial therapy is impossible without iden-
tifying the etiologic agent. Investigations of the speciﬁc
pathogens causing intraamniotic, postpartum, and post-
surgical infections have shown that the primary causative
agents change over time. For example, the principal etiol-
ogy of early onset neonatal sepsis has ranged from GAS
in the 1930s–1940s, E. coli in the 1940s–1970s, to group
B streptococci in the current era [37]. Also, recent stud-
ies have documented an increase in the proportion of
healthcare-associated bloodstream infections and the emer-
gence of community-associated methicillin-resistant Staphy-
lococcus aureus infections among pregnant and postsurgical
patients [38–40]. Comprehensive studies to evaluate the eti-
ologies of pregnancy-related infections have not been per-
formed for over 15 years [41–45]. Periodic evaluations of the
etiologies of pregnancy-related infections and the prevalence
of antibiotic-resistant isolates among this population would
be useful.
Another beneﬁt of obtaining pretreatment cultures is
that identiﬁcation of certain pathogens, such as GAS, should
trigger speciﬁc infection control measures to prevent spread
of disease. GAS infections can be devastating with an overall
case fatality ratio (CFR) of 13% and CFRs of 25–36% for the
most severe manifestations—necrotizing fasciitis and strep-
tococcal toxic shock syndrome [46]. These infections are not
rare; using the results of our survey of ∼3% of the nation’s
OB/GYNs, we estimate that approximately 2600 postpartum
and 2700 postsurgical GAS infections occur annually in the
UnitedStates.Healthcare-associatedtransmissionofGASin-
fections can sometimes be prevented, for example, in in-
stances where an asymptomatic colonized healthcare worker
is identiﬁed and treated as a result of a thorough epidemio-
logic investigation [27].
Provider responses to the GAS-speciﬁc questions in-
cluded in our survey underscore both the lack of aware-
ness of the CDC GAS guidelines among one of their tar-
geted audiences—OB/GYNs—and potential means to cor-
rect this information gap. Very few providers were aware of
the guidelines and the recommended public health action
following identiﬁcation of postpartum and postsurgical GAS
infections.Theprincipalreasonfornotunderstandingorfol-
lowing these guidelines was a lack of awareness of their exis-
tence, most likely because they were published in a journal
not read by this group of providers. Potential solutions to
this dilemma include publication in journals relevant to OB-
GYNs, incorporation into ACOG guidelines and hospital in-
fection control protocols, presentation at relevant meetings,
and inclusion in CME lecture series.
A common thread in our survey results is the association
of increasing years of experience and older age with a variety
of practice patterns. Older, more experienced providers were
far more likely to attempt to determine the etiology of intra-
andpostpartuminfectionsandalsohaddiﬀerentbeliefsfrom
younger providers as to the speciﬁc etiologies of such infec-
tions.The reasons for these trends are unknown but may in-
clude changes in medical education or in the epidemiology
of these infections.
Limitations of our survey include our low response rate,
particularly among non-CARN providers although it is con-
sistentwithotherACOGsurveys[47,48].Animportantlim-
itation is that we were unable to validate the estimated num-
berofproceduresperformedandactualpracticesreportedby
the respondents. It is possible that the frequencies of infec-
tions reported are signiﬁcantly underestimated. Also, given
the low number of providers who were aware of the CDC
guidelines for postpartum and postsurgical GAS infections,
attempts to estimate the respondents’ understanding of spe-
ciﬁc aspects of these guidelines are of limited value.
In summary, although the use of empiric antibiotics in
intraamniotic, postpartum, and postsurgical infections may
currently be eﬀective in most cases, the paucity of diagnostic
cultures obtained presents a missed opportunity to monitor
the etiology of these infections and to identify a potentially
preventable cause of serious healthcare-associated disease—
GAS infections. Current eﬀorts to educate providers regard-
ing the settings in which the identiﬁcation of GAS should
trigger a public health response and augment infection con-
trol practices are inadequate. However, our survey iden-
tiﬁed more eﬀective means of communicating with prac-
ticing OB/GYNs and also emphasized that educational ef-
forts should target the infection control practitioner (ICP)
as most hospitals currently rely on the ICP to identify po-
tential healthcare-associated infections and initiate necessary
investigations. Periodic, time-limited studies of the etiolo-
gies of pregnancy-related infections by public health and
clinical researchers would help to monitor changes in theChris A. Van Beneden et al. 7
principal pathogens, track trends in antimicrobial resistance,
and guide clinical management.
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